At A Glance:

This was an important Phase III, 2-protocol study for a first-in-class treatment of abdominal uterine bleeding in women with uterine fibroids.

Download PDF
Indication:

Uterine Fibroids


Enrollment time saved (Protocol 1) 20 months
Enrollment time saved (Protocol 2) 8 months
See the results